g10 fx
SalMar: stronger biology points to earnings upgrades, says SEB analyst - Salmon Business
From the original
SalMar: stronger biology points to earnings upgrades, says SEB analyst Salmon Business
Related speeches
4 itemsSEB: Mowi earnings forecasts cut, but Buy rating retained - Salmon Business
SEB: consensus earnings forecasts still too high - SalmonBusiness
Mowi: SEB raises Q3 EBIT forecast, reiterates Buy ahead of trading update - Salmon Business
Analysts: Mowi’s surprise cost gains point to higher profits ahead - Salmon Business
More like this
5 itemsOMXS30 closes 81 points lower as SEB weighs - AD HOC NEWS
Earnings call transcript: Groupe SEB Q3 2026 sales flat as stock falls 3.1% - Investing.com
Earnings call transcript: Groupe SEB Q3 2026 sales flat as stock falls 3.1% - Investing.com India
Earnings call transcript: Groupe SEB Q3 2026 sales flat as stock falls 3.1% - Investing.com Canada